Meeting Report
An AP Perspective on Infusion Reactions in the Era of Immunotherapy
Carrie Peterson, DNP, RN, AGNP-c
From Dignity Health Cancer Institute, Phoenix, Arizona
Presenter’s disclosure of conflicts of interest is found at the end of this article.
J Adv Pract Oncol 2022;13(3):247–252 |
https://doi.org/10.6004/jadpro.2022.13.3.13 |
© 2022 Harborside™
ABSTRACT
As cancer care advances, creative uses for immunotherapy continue to be developed, but it is also important to be cognizant of the risk for infusion reactions. At JADPRO Live Virtual 2021, Carrie Peterson, DNP, RN, AGNP-c, reviewed the different classes and pathophysiology of immunotherapy, how to anticipate potential infusion reactions for each class of immunotherapy, and how to identify and treat infusion reactions during infusion of immunotherapy so that patients can stay on treatment.
For access to the full length article, please
sign in.
